Neuromuscular complications in endocrine and metabolic disorders

Veterinary Clinics of North America - Small Animal Practice

Volumn 32, Issue 1, 2002, Pages 125-146

  R Platt, Simon ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; ELECTROLYTE; GLUCOCORTICOID; GLYCOGEN; GROWTH HORMONE; INSULIN; LIPID; PARATHYROID GLAND HORMONE; STEROID; THYROID HORMONE;

ACROMEGALY; ADRENAL CORTEX INSUFFICIENCY; CAT; CLINICAL FEATURE; CUSHING SYNDROME; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE MODEL; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DISORDERS OF MINERAL, ELECTROLYTE AND METAL METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DISORDERS OF STEROID METABOLISM; DOG; ENDOCRINE DISEASE; GLYCOGEN STORAGE DISEASE; HYPERADRENOCORTICISM; HYPERINSULINISM; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOPARATHYROIDISM; HYPOPHYSIS DISEASE; HYPOPITUITARISM; HYPOTHYROIDISM; METABOLIC DISORDER; MUSCLE BIOPSY; NEUROMUSCULAR DISEASE; NONHUMAN; PANCREAS ISLET CELL TUMOR; PARATHYROID DISEASE; REVIEW; THYROID DISEASE;

CANIS FAMILIARIS; FELIS CATUS;

EID: 0036143790     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00082-2     Document Type: Review

References (84)

1. Endocrine myopathies
2. Reversible megaesophagus associated with atypical primary hypoadrenocorticism in a dog
3. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies
4. Experimental investigation of glucocorticoid-induced myopathy in the dog
5. Subclinical myopathy associated with hyperadrenocorticism in the dog
6. Hypothyroid myopathy in two dogs
7. Episodic weakness associated with exertional lactic acidosis and myopathy in Old English Sheepdog littermates
8. Nemaline rods in neuromuscular disorders of the dog
9. Skeletal muscle function
10. Glycogenosis type III in the dog
11. Effects of altered thyroid status on beta-adrenergic actions on skeletal muscle glycogen metabolism
12. Clinical presentation of some newer myopathies
13. Nemaline rods in canine myopathies: 4 case reports and literature review
14. Disorders of lipid metabolism affecting skeletal muscle: Carnitine deficiency syndromes, defects in the catabolic pathway, and Chanarin disease
15. Hypodipsic hypernatremia and associated myopathy in a hydrocephalic cat with transient hypopituitarism
16. Hypokalemia in cats: 186 cases (1984-1987)
17. Potassium depletion in cats: Hypokalemic polymyopathy
18. Potassium depletion in cats: Renal and dietary influences
19. Neuromuscular findings in thyroid dysfunction: A prospective clinical and electrodiagnostic study
20. NA(+)-K + pump in rat muscle: Effects of hypophysectomy, growth hormone and thyroid hormone
21. Canine primary hyperparathyroidism
22. Disorders of the parathyroid glands
23. Hyperadrenocorticism
24. Familial myoclonic epilepsy in the miniature wire-haired dachshund
25. Molecular characterization of the feline glycogen storage disease type IV
26. Glycogen storage disease type IV: Inherited deficiency of branching enzyme activity in cats
27. Autosomal recessive inherited phosphofructokinase deficiency in English Springer Spaniel dogs
28. Inherited phosphofructokinase deficiency in an American Cocker spaniel
29. Metabolic myopathy in canine muscle-type phosphofructokinase deficiency
30. Myopathy associated with hyperadrenocorticism in the dog
31. Suspect hypokalemic myopathy in a dog
32. Polysaccharide storage myopathy in canine phosphofructokinase deficiency (type VII glycogen storage disease)
33. Collapding clumber spaniels
34. Endocrine myopathies
35. Mitochondrial myopathy in the Sussex spaniel
36. Role of glucocorticoids in the response of rat leg muscles to reduced activity
37. Hyperkalemic periodic paralysis in a dog
38. Hypokalemic myopathy in cats
39. Lafora's disease (progressive myoclonus epilepsy) in the Basset Hound - Early diagnosis by muscle biopsy
40. Endocrine myopathies (hyper- and hypofunction of the adrenal, thyroid, pituitary, and parathyroid glands and iatrogenic corticosteroid myopathy)
41. Neuromuscular manifestations of electrolyte disorders
42. Neuropathy associated with diabetes mellitus in the cat
43. Metabolic and endocrine myopathies of dogs and cats
44. Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects
45. Glucocorticoid deficient hypoadrenocorticism in dogs:18 cases (1985-1995)
46. Diabetic neuropathy
47. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes
48. Altered neuroexcitability in experimental diabetic neuropathy: Effect of acetyl-L-carnitine
49. Lactic acidemia and lactate/pyruvate ratios
50. Changes in body temperature and hematologic, biochemical, blood gas and acid base values in healthy Labrador retrievers before and after strenuous exercise
51. Interaction of glucocorticoids and androgens and skeletal muscle
52. The role of insulin, corticosterone and other factors in the acute recovery of muscle protein synthesis on refeeding food-deprived rats
53. Long-term complications of diabetes mellitus, Part I: Retinopathy, nephropathy, neuropathy
54. Acute onset of hypokalemia and muscular weakness in four hyperthyroid cats
55. Suspected mitochondrial myopathy in a Jack Russell terrier
56. Organic acidurias: A review. Part 1
57. Endocrine diseases
58. Feline acromegaly (growth hormone excess)
59. Hyperthyroidism
60. Lipid storage myopathy in a cocker spaniel
61. Glycogenosis in the dog
62. Clinical signs and laboratory abnormalities in 23 dogs with spontaneous hypoadrenocorticism
63. Effects of glucocorticoids on motor units in cat hindlimb muscles
64. Lactic acidemia
65. Atypical hypoadrenocorticism in three dogs
66. Endocrine myopathies
67. Thyroid hormone induces a nerve-independent precocious expression of fast myosin heavy chain mRNA in rat hindlimb skeletal muscle
68. A clinical survey of 48 dogs with adrenocortical hypofunction
69. Hypothyroidism
70. Canine lipid storage myopathies
71. Pathophysiologic basis of canine muscle disorders
72. Acquired myasthenia gravis in hyperthyroid cats on Tapazole therapy
73. Analysis of organic acids, amino acids, and carnitine in dogs with lipid storage myopathy
74. Pyruvate dehydrogenase deficiency in Clumber and Sussex spaniels in the United States and Belgium
75. Myofibrillar protein catabolism in rat steroid myopathy measured by 3-methylhistidine excretion in the urine
76. Influence of glucocorticoids on skeletal muscle proteolysis in normal and diabetic-adrenalectomized eviscerated rats
77. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects
78. Interactive effects of insulin and corticosterone on myofibrillar protein turnover in rats as determined by N tau-methylhistidine excretion
79. Canine mitochondrial myopathy associated with reduced mitochondrial mRNA and altered cytochrome c oxidase activities in fibroblasts and skeletal muscle
80. Mitochondrial defects in cardiomyopathy and neuromuscular disease
81. Canine glycogen storage disease type II: A biochemical study of an acid α-glucosidase-deficient Lapland dog
82. Canine glycogen storage disease type II: A clinical study of four affected Lapland dogs
83. Canine hypoadrenocorticism: Report of 37 cases and review of 39 previously reported cases